NCT04697303

Brief Summary

Understanding the quality of life and anorectal function changes in patients with middle and low rectal cancer after surgery can guide patients to recover after surgery and provide a valuable reference for surgeons in the selection of surgical methods. The purpose of this study is to: (1) Investigate the complication rate, recurrence and metastasis rate and survival of patients with middle and low rectal cancer. (2) QLQ-C30 and QLQ-CR29 questionnaires were used to assess the quality of life of patients with low- and middle-level rectal cancer at different periods after surgery. (3) Wexner constipation score and LARS syndrome score for anorectal function after operation for low rectal cancer. (4) The CIPE ejaculatory function score, IIEF-5 International Erectile Function Score, and FSFI-6 Female Sexual Function Index were used to assess the changes in sexual function of patients with low- and middle-position rectal cancer after surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 26, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 1, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 6, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2021

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 28, 2021

Completed
Last Updated

April 8, 2021

Status Verified

April 1, 2021

Enrollment Period

4 months

First QC Date

January 1, 2021

Last Update Submit

April 6, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Overall survival

    defined as time from the date of sugery to death

    five years after the operation

Secondary Outcomes (7)

  • QLQ-C30

    Every three months after the operation

  • QLQ-CR29

    Every three months after the operation

  • Wexner

    Every three months after the operation

  • LARS

    Every three months after the operation

  • IIEF-5

    Every three months after the operation

  • +2 more secondary outcomes

Study Arms (1)

Middle and low rectal cancer

Other: anorectal function test

Interventions

anorectal function test

Middle and low rectal cancer

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Postoperative patients with middle and low rectal cancer

You may qualify if:

  • Postoperative patients with middle rectal cancer
  • Postoperative patients with low rectal cancer

You may not qualify if:

  • (1)Patients refused to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jilin University First Hospital

Changchun, Jilin, 130021, China

Location

MeSH Terms

Conditions

Rectal Neoplasms

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesIntestinal DiseasesRectal Diseases

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 1, 2021

First Posted

January 6, 2021

Study Start

October 26, 2020

Primary Completion

February 28, 2021

Study Completion

March 28, 2021

Last Updated

April 8, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share

Locations